CRMD
CorMedix Inc.
Key Financials
Operating Income
$150.1M
↑ 771.6%
Net Income
$163.1M
↑ 1009.4%
Gross Profit
$275.7M
↑ 584.6%
Revenue
$311.7M
↑ 617.0%
EPS (Diluted)
$2.04
↑ 780.0%
Total Assets
$826.1M
↑ 595.1%
Shareholders' Equity
$405.3M
↑ 378.8%
Total Liabilities
$420.8M
↑ 1130.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CRMD |
| Company Name | CorMedix Inc. |
| CIK | 1410098 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 908-517-9500 |